City Holding Co’s Neurocrine Biosciences NBIX Stock Holding History

City Holding Co’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9K	Hold	100	–	–	﹤0.01%	459
2026 Q1	$13.2K	Hold	100	–	–	﹤0.01%	446
2025 Q4	$14.2K	Hold	100	–	–	﹤0.01%	450
2025 Q3	$14K	Hold	100	–	–	﹤0.01%	453
2025 Q2	$12.6K	Hold	100	–	–	﹤0.01%	406
2025 Q1	$11.1K	Hold	100	–	–	﹤0.01%	480
2024 Q4	$13.7K	Hold	100	–	–	﹤0.01%	390
2024 Q3	$11.5K	Buy	+100	New	+$13.7K	﹤0.01%	396

Other funds holding NBIX

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return

Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return

Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return